Mayo Clinic wins and cancer data lift healthcare stocks as buyers chase proof, not promises

• Amplia Therapeutics (ASX:ATX) surged on pancreatic cancer results, but the move cooled after a sharp reopen
• Echo IQ (ASX:EIQ) and 4DMedical (ASX:4DX) jumped after Mayo Clinic-linked adoption and distribution wins
• Lumos Diagnostics (ASX:LDX) landed a US waiver that lets FebriDx be used in far more clinics and pharmacies
• Cyclopharm (ASX:CYC) added more US hospital sites, which matters because Technegas pays again via consumables